Atomic AI Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $35M

  • Investors
  • 16

Atomic AI General Information

Description

Operator of a content intelligence platform designed to enable the rational design of new molecules and medicine using AI. The company develops and builds an AI platform that utilizes engagement data from clients' analytics platforms to gather intelligence and formulate predictive reports on topics, publishing times, and distribution channels, enabling users with new strategies to treat or cure diseases by targeting RNA structure.

Contact Information

Website
www.atomic.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 329 Oyster Point Boulevard
  • 3rd Floor
  • San Francisco, CA 94080
  • United States
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • 329 Oyster Point Boulevard
  • 3rd Floor
  • San Francisco, CA 94080
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Atomic AI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 25-Jan-2023 $35M Completed Generating Revenue
1. Seed Round 20-Aug-2021 Completed Generating Revenue
To view Atomic AI’s complete valuation and funding history, request access »

Atomic AI Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-2
Series A-1
Seed-2 141,767 $0.000010 $1.76 $1.76 1x $1.76 0.62%
Seed-1 2,901,744 $0.000010 $2.07 $2.07 1x $2.07 12.75%
To view Atomic AI’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Atomic AI Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a content intelligence platform designed to enable the rational design of new molecules and medicine using A
Discovery Tools (Healthcare)
San Francisco, CA
27 As of 2026

Tel Aviv, Israel
 

Wilmington, DE
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Atomic AI Competitors (2)

One of Atomic AI’s 2 competitors is Enso (Business/Productivity Software), a Venture Capital-Backed company based in Tel Aviv, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Enso (Business/Productivity Software) Venture Capital-Backed Tel Aviv, Israel
Enso (Wilmington) Venture Capital-Backed Wilmington, DE
You’re viewing 2 of 2 competitors. Get the full list »

Atomic AI Patents

Atomic AI Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4721079-A1 Machine-learning foundation model for generating biopolymer embeddings Pending 05-Jun-2023
US-20240404649-A1 Machine-learning foundation model for generating biopolymer embeddings Pending 05-Jun-2023
WO-2024254090-A1 Machine-learning foundation model for generating biopolymer embeddings Inactive 05-Jun-2023
EP-4573503-A1 Methods, systems, and media method applying machine learning to chemical mapping data for rna tertiary structure prediction Pending 19-Aug-2022
EP-4573503-A4 Methods, systems, and media method applying machine learning to chemical mapping data for rna tertiary structure prediction Pending 19-Aug-2022 G16B15/10
To view Atomic AI’s complete patent history, request access »

Atomic AI Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atomic AI Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Modi Ventures Venture Capital Minority
Angel (individual) Minority
Angel (individual) Minority
Not Boring Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 16 investors. Get the full list »

Atomic AI FAQs

  • When was Atomic AI founded?

    Atomic AI was founded in 2021.

  • Where is Atomic AI headquartered?

    Atomic AI is headquartered in San Francisco, CA.

  • What is the size of Atomic AI?

    Atomic AI has 27 total employees.

  • What industry is Atomic AI in?

    Atomic AI’s primary industry is Discovery Tools (Healthcare).

  • Is Atomic AI a private or public company?

    Atomic AI is a Private company.

  • What is the current valuation of Atomic AI?

    The current valuation of Atomic AI is .

  • What is Atomic AI’s current revenue?

    The current revenue for Atomic AI is .

  • How much funding has Atomic AI raised over time?

    Atomic AI has raised $42M.

  • Who are Atomic AI’s investors?

    Modi Ventures, , , Not Boring, and are 5 of 16 investors who have invested in Atomic AI.

  • Who are Atomic AI’s competitors?

    Enso (Business/Productivity Software) and Enso (Wilmington) are competitors of Atomic AI.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process